Washington Trust Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65K Sell
12
-113
-90% -$31.3K ﹤0.01% 615
2026
Q1
$36.9K Buy
125
+26
+26% +$7.72K ﹤0.01% 388
2025
Q4
$27K Hold
99
– – ﹤0.01% 400
2025
Q3
$26.7K Hold
99
– – ﹤0.01% 411
2025
Q2
$27.3K Hold
99
– – ﹤0.01% 373
2025
Q1
$26.3K Hold
99
– – ﹤0.01% 373
2024
Q4
$23K Hold
99
– – ﹤0.01% 391
2024
Q3
$21.8K Hold
99
– – ﹤0.01% 401
2024
Q2
$19.5K Buy
+99
New +$20.5K ﹤0.01% 407
2022
Q2
– Sell
-6
Closed -$1K – 944
2022
Q1
$1K Hold
6
– – ﹤0.01% 975
2021
Q4
$1K Buy
+6
New +$1.32K ﹤0.01% 980

Other funds holding CME

Washington Trust Advisors's CME Position: Q2 2026 in Review

Washington Trust Advisors reduced its CME Group (CME) stake by 90% in Q2 2026, selling an estimated $31.3K and leaving 12 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #615.

Washington Trust Advisors first reported a position in CME in Q4 2021 and has held it in 11 quarters since. The position peaked at $36.9K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Washington Trust Advisors held 12 shares of CME Group worth $2.65K as of Q2 2026.
  • Washington Trust Advisors sold 113 CME Group shares in Q2 2026, an estimated $31.3K.
  • CME Group made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #615 holding.
  • Washington Trust Advisors first reported a position in CME Group in Q4 2021 and has held it in 11 quarters since.
  • Washington Trust Advisors's CME Group position peaked at $36.9K in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.